Skip to content
Research Article Open access CC BY 4.0

Advancements in Precision Medicine for Myelodysplastic Neoplasms and Acute Myeloid Leukemia: A Review on Genomics to Targeted Therapies

Eric Emmanuel U, Eberechukwu G C, Boloya V. E

Asian Oncology Research Journal · pp. 28–33 · Published 16 Jan 2026

10.9734/aorj/2026/v9i1123

Abstract

Myelodysplastic neoplasms (MDS) and acute myeloid leukemia (AML) are clonal hematopoietic disorders characterized by ineffective hematopoiesis and rapid proliferation of abnormal myeloid cells, respectively. Recent advances in molecular biology have significantly enhanced our understanding of the pathogenesis of MDS and AML, leading to improved diagnostic methods and novel therapeutic strategies. This review highlights the latest developments in genetic and epigenetic alterations, the role of the bone marrow microenvironment, advancements in diagnostics, targeted therapies, immunotherapies, and personalized medicine approaches in MDS and AML. Challenges and future directions are also discussed to provide a comprehensive overview of the current landscape and potential advancements in the management of these hematologic malignancies.

Myelodysplastic neoplasms acute myeloid leukemia genetic mutations epigenetic alterations

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.